Matches in Wikidata for { <http://www.wikidata.org/entity/Q74275049> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q74275049 description "clinical trial" @default.
- Q74275049 description "ensayu clínicu" @default.
- Q74275049 description "klinisch onderzoek" @default.
- Q74275049 description "клінічне випробування" @default.
- Q74275049 name "Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer" @default.
- Q74275049 name "Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer" @default.
- Q74275049 type Item @default.
- Q74275049 label "Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer" @default.
- Q74275049 label "Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer" @default.
- Q74275049 prefLabel "Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer" @default.
- Q74275049 prefLabel "Testing the Addition of the Drugs, Apalutamide and Abiraterone Acetate With Prednisone, to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer" @default.
- Q74275049 P1050 Q74275049-2D89604E-7A8E-4A37-8790-632E2380CD46 @default.
- Q74275049 P1132 Q74275049-330B6F03-32EE-469A-8C81-0C2A42C3B771 @default.
- Q74275049 P1476 Q74275049-4C7882C9-E0A9-4DDF-BB87-408F998293B9 @default.
- Q74275049 P2899 Q74275049-E801FB2D-6A92-4D2F-8DC9-777D90544ECC @default.
- Q74275049 P3098 Q74275049-76480DFC-8B00-4243-83A1-BEB591480379 @default.
- Q74275049 P31 Q74275049-B5492050-4A83-4DE0-AA8B-3619BE437FC6 @default.
- Q74275049 P4844 Q74275049-5229152A-E31A-4AAA-B330-825EC6AC2044 @default.
- Q74275049 P4844 Q74275049-D75419A8-99AB-475C-BDF2-9C79C67B9F15 @default.
- Q74275049 P580 Q74275049-04FEBFD4-1CF1-4E56-8E3D-D2EA420EEE4D @default.
- Q74275049 P582 Q74275049-3FB12D86-29AC-4371-A3BE-E6CD2F23144E @default.
- Q74275049 P6099 Q74275049-3BCDB976-CE36-49C5-9B3C-84B4E0845BA1 @default.
- Q74275049 P8363 Q74275049-193EE8DA-D3EF-4212-8123-0E169B799693 @default.
- Q74275049 P859 Q74275049-1922DA59-2B45-495F-848F-304A0459AE4E @default.
- Q74275049 P1050 Q356033 @default.
- Q74275049 P1132 "+586" @default.
- Q74275049 P1476 "Randomized Phase III Trial Incorporating Abiraterone Acetate With Prednisone and Apalutamide and Advanced Imaging Into Salvage Treatment for Patients With Node-Positive Prostate Cancer After Radical Prostatectomy" @default.
- Q74275049 P2899 "+18" @default.
- Q74275049 P3098 "NCT04134260" @default.
- Q74275049 P31 Q30612 @default.
- Q74275049 P4844 Q39045244 @default.
- Q74275049 P4844 Q424972 @default.
- Q74275049 P580 "2020-03-19T00:00:00Z" @default.
- Q74275049 P582 "2026-11-01T00:00:00Z" @default.
- Q74275049 P6099 Q42824827 @default.
- Q74275049 P8363 Q78089383 @default.
- Q74275049 P859 Q30270252 @default.